Author response for "Impaired Virus‐Specific T Cell Responses in Patients with Myeloproliferative Neoplasms Treated with Ruxolitinib"

2020 ◽  
Author(s):  
Elisa Rumi ◽  
Emanuela Sant'Antonio ◽  
Chiara Cavalloni ◽  
Giuditta Comolli ◽  
Virginia Valeria Ferretti ◽  
...  
Keyword(s):  
T Cell ◽  
Myeloproliferative Neoplasms ◽  
T Cell Responses ◽  
Author Response ◽  
Cell Responses

scholarly journals Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation

2018 ◽  
Vol 7 (9) ◽  
pp. e1468957 ◽  
Author(s):  
Mia Aaboe Jørgensen ◽  
Morten Orebo Holmström ◽  
Evelina Martinenaite ◽  
Caroline Hasselbalch Riley ◽  
Hans Carl Hasselbalch ◽  
...  
Keyword(s):  
T Cell ◽  
Myeloproliferative Neoplasms ◽  
T Cell Responses ◽  
Driver Mutation ◽  
Disease Stage ◽  
Chronic Myeloproliferative Neoplasms ◽  
Cell Responses ◽  
Arginase 1

scholarly journals Author response for "Accelerated thymopoiesis and improved T cell responses in HLA‐A2/‐DR2 transgenic BRGS‐based human immune system mice"

2019 ◽  
Author(s):  
Guillemette Masse‐Ranson ◽  
Mathilde Dusséaux ◽  
Oriane Fiquet ◽  
Sylvie Darche ◽  
Maud Boussand ◽  
...  
Keyword(s):  
Immune System ◽  
T Cell ◽  
T Cell Responses ◽  
Author Response ◽  
Human Immune System ◽  
Cell Responses ◽  
Human Immune

Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib

2020 ◽  
Vol 38 (4) ◽  
pp. 554-559
Author(s):  
Elisa Rumi ◽  
Emanuela Sant'Antonio ◽  
Chiara Cavalloni ◽  
Giuditta Comolli ◽  
Virginia Valeria Ferretti ◽  
...  
Keyword(s):  
T Cell ◽  
Myeloproliferative Neoplasms ◽  
T Cell Responses ◽  
Cell Responses
Sign in / Sign up

Export Citation Format

Share Document